Do More With Reuters
Partner Services

UPDATE 1-AEterna Zentaris doubles first-quarter loss

Wed May 7, 2008 5:38pm IST
 
Email | Print | | Single Page
[-] Text [+]

(In U.S. dollars. Adds details)

TORONTO, May 7 (Reuters) - AEterna Zentaris Inc (AEZ.TO: Quote, Profile, Research) said on Wednesday that its first-quarter loss more than doubled due to higher research and development expenses for its enlarged prostate gland treatment.

The biopharmaceuticals company said it lost $10.9 million, or 20 cents a share in the period ended March 31, compared with a loss of $5.1 million, or 10 cents a share, during the same period a year earlier.

Revenue for the quarter was $9.7 million, up 5.6 percent from $9.2 million in the same period in 2007.

Analysts were expecting a loss of 24 cents a share on revenue of $9.8 million.

The company, which specializes in endocrinology and oncology treatments, said research and development expenses were $13.7 million for the first quarter, up from $7.9 million for the same time last year as it ramped up development of its lead product cetrorelix which is in Phase 3 trials.

Typically expenses will mount for biotechnology companies as they advance further into trials before receiving regulatory approval. ($1=$1.00 Canadian) (Reporting by Scott Anderson; editing by Renato Andrade)

Dubai Debt Fears

Villas are seen on the The Palm, Jumeirah, with Atlantis, The Palm, under construction on the breakwater (crescent), May 3, 2008.  REUTERS/Jumana El Heloueh

Banks outside the Gulf played down their exposure to Dubai debt, after fears the emirate could default and even derail world economic recovery prompted a sell-off in global markets.  Full Article | Slideshow 

India Investment Summit 2009
India Investment Summit 2009

Top executives and bankers discuss their own plans and the broader opportunities and challenges for India.  Full Coverage 

People stroll outside the Taj Mahal hotel ahead of the first anniversary of the militant attacks in Mumbai, November 24, 2009.  REUTERS/Punit Paranjpe
Investors worry about another attack

The risk of militants striking again worries investors who fear that a second attack similar to last year's Mumbai raids could shake the economy.  Full Article | Full Coverage 

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

road to Copenhagen

BLOGS

Photo
Calculated Move

Reliance aims big with $12 bln bid for LyondellBasell.  Blog 

SHOWCASE

Capital Raising
Capital Raising

Analysis - China banks' rush for billions could trip markets.  Full Article 

 
Photo
Bonus Payout

"Bonus" has become a dirty word on Wall Street.  Full Article 

 
Bubble trouble?
Bubble trouble?

With the BSE Sensex at around 17,000 points, are the Indian equity markets looking at a possible bubble?   Commentary 

 
Funding Blues
Funding Blues

A popular tactic used by Indian brokerages to raise money for rich clients is likely to be banned.  Full Article 

 
Recovery Path
Recovery Path

Indian techie logging out of downturn gloom.  Full Article 

 
Central Banks Cautious
Central Banks Cautious

Reuters tracks the policies of the world's top central banks as the debate over global economic recovery rages on.   Full Coverage 

 
Risky Proposal
Risky Proposal

Rupert Murdoch courts trouble if he blocks Google on news.  Full Article